|

Effects of Remote Ischaemic Preconditioning in Cemented Hip Arthroplasty.

RECRUITINGN/ASponsored by University of Tartu
Actively Recruiting
PhaseN/A
SponsorUniversity of Tartu
Started2024-03-20
Est. completion2026-03
Eligibility
Age65 Years – 90 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06323018

Summary

Total joint arthroplasty is one of the best treatment options for end-stage osteoarthritis. Cemented hip arthroplasty is mainly indicated for elderly patients with poor bone quality and multiple comorbidities. Bone cement implantation syndrome is associated with cemented hip arthroplasty and it has been shown to increase cardiovascular and renal complication and brain damage postoperatively. The aim of this project is to elucidate whether remote-ischemic preconditioning (RIPC) has multi-organ protective effect in cemented hip arthroplasty patients.

Eligibility

Age: 65 Years – 90 YearsHealthy volunteers accepted
Inclusion Criteria:

* age \>65 years
* undergoing total hip cemented hip arthroplasty

Exclusion Criteria:

* previously diagnosed peripheral artery disease on both upper limb
* RIPC is contraindicated

Conditions5

ArthritisBone Cement Implantation SyndromeCardiovascular DiseasesKidney DiseasesOsteoarthritis, Hip

Browse More Trials

Arthritis trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.